2025 Investor Attendees
| Company Name |
| 1004 Venture Partners |
| AAA Family Office |
| Abbvie Ventures c/o DJS |
| Almaral |
| Almaral |
| Andera Partners |
| Astellas |
| Avant Bio |
| Beyond Impact |
| Biovision Ventures |
| Bootstrap Europe |
| Boundless Health Capital |
| Chiesi USA |
| Circle 7 capital |
| Claret Capital Partners |
| Crown Global Capital |
| CVX Ventures |
| Eir Ventures Partners |
| Eir Ventures Partners |
| Eitri Innovation Center & Health Incubator |
| Endeavor Venture Group |
| FaaS Capital |
| Farvatn |
| Fenja Capital |
| Fenja Capital |
| FLC Investments AS |
| Flerie |
| Frumtak Ventures |
| Fund+ |
| Gilde Healthcare |
| GrayBella Capital |
| Hadean Ventures |
| Hadean Ventures AS |
| Haukeland University Hospital |
| Health Cap |
| Heran Partners |
| HERAN Partners BV |
| Indaco Bio Fund |
| Industrifonden |
| Industrifonden |
| Innovestor Life Science Oy |
| Investinor |
| Investinor |
| Investinor AS |
| Investinor AS |
| IPF Partners |
| Karolinska Development |
| Life Science Invest AB |
| LU Ventures AB |
| Maruho Deutschland GmbH |
| Maudsley Enterprise |
| Merieux Equity Partners |
| Mérieux Equity Partners |
| Mérieux Equity Partners |
| NLC Ventures BV |
| Nordic Science Investments |
| Novo Holdings |
| Novo Holdings |
| Novo Holdings A/S |
| Ontogeny / MTI Vekst |
| Opulentia Invest AS |
| p53 Invest |
| Rethink Capital AB |
| Rethink Capital AB |
| Sandwater |
| Sarsia |
| Sarsia |
| Sarsia Management AS |
| Sarsia Management AS |
| Sarsia Management AS |
| Sarsia Management AS |
| Segulah Medical Acceleration |
| Segulah Medical Acceleration |
| SmiLe Inject Capital |
| Sound Bioventures |
| Stokke Industri AS |
| Sunstone Life Science Ventures |
| Tesi |
| Torrey Pines Investments |
| Trill Impact |
| Voima Ventures |
| WAVE Equity Partners |
| Zcube, Zambon Research Venture |
